CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
Year: 2018
Type: article
Study design: Observational Study
Source: Clinical Cancer Research
Authors: Jarem Edwards, James S. Wilmott, Jason Madore, Tuba Nur Gide, Camelia Quek, Annie Tasker, Angela Ferguson, Jinbiao Chen, Rehana Hewavisenti, Peter Hersey, Thomas Gebhardt, Wolfgang Weninger, Warwick J. Britton, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Georgina V. Long, Richard A. Scolyer, Umaimainthan Palendira
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: Improving clinical outcomes of melanoma patients, The mutational landscape of melanoma in adolescents and young adults, Molecular determinants of risk, progression and treatment response in melanoma, G6699405209, Development of systemic therapies to improve response and prevent resistance in the treatment of Melanoma
OpenAlex ID: W2795035720
